Protagonist Therapeutics falls amid a report J&J deal price may be lower (PTGX:NASDAQ)

Protagonist Therapeutics (NASDAQ:PTGX) dropped 5% after a report that the Johnson & Johnson (NYSE:JNJ) takeover price may be lower than the current share price. Blackstone is to speculated to be the private equity firm working with Johnson & Johnson ( ...